OpenURL Connection Search

Select item for more details and to access through your institution.

Epigenetic regulation of inflammation in localized aggressive periodontitis.
Published in:
Clinical Epigenetics, 2017, v. 9, n. 1, p. 1, doi. 10.1186/s13148-017-0385-8
By:
- Shaddox, L. M.;
- Mullersman, A. F.;
- H. Huang;
- Wallet, S. M.;
- Langaee, T.;
- Aukhil, I.
Publication type:
Article
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
Published in:
Pharmacogenomics Journal, 2013, v. 13, n. 5, p. 430, doi. 10.1038/tpj.2012.34
By:
- Karnes, J H;
- McDonough, C W;
- Gong, Y;
- Vo, T T;
- Langaee, T Y;
- Chapman, A B;
- Gums, J G;
- Beitelshees, A L;
- Bailey, K R;
- Del-Aguila, J L;
- Boerwinkle, E A;
- Pepine, C J;
- Turner, S T;
- Johnson, J A;
- Cooper-DeHoff, R M
Publication type:
Article
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
Published in:
Pharmacogenomics Journal, 2013, v. 13, n. 3, p. 257, doi. 10.1038/tpj.2012.4
By:
- Duarte, J D;
- Turner, S T;
- Tran, B;
- Chapman, A B;
- Bailey, K R;
- Gong, Y;
- Gums, J G;
- Langaee, T Y;
- Beitelshees, A L;
- Cooper-Dehoff, R M;
- Boerwinkle, E;
- Johnson, J A
Publication type:
Article
Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans.
Published in:
Clinical Pharmacology & Therapeutics, 2010, v. 87, n. 4, p. 459, doi. 10.1038/clpt.2009.223
By:
- Cavallari, L. H.;
- Langaee, T. Y.;
- Momary, K. M.;
- Shapiro, N. L.;
- Nutescu, E. A.;
- Coty, W. A.;
- Viana, M. A. G.;
- Patel, S. R.;
- Johnson, J. A.
Publication type:
Article
Promoter Polymorphisms in ACE (Angiotensin I–Converting Enzyme) Associated With Clinical Outcomes in Hypertension.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 1, p. 36, doi. 10.1038/clpt.2008.194
By:
- Johnson, A. D.;
- Gong, Y.;
- Wang, D.;
- Langaee, T. Y.;
- Shin, J.;
- Cooper-DeHoff, R. M.;
- Schork, N. J.;
- Binkley, P.;
- Pepine, C. J.;
- Johnson, J. A.;
- Sadee, W.
Publication type:
Article
β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension.
Published in:
Clinical Pharmacology & Therapeutics, 2008, v. 84, n. 6, p. 715, doi. 10.1038/clpt.2008.139
By:
- Pacanowski, M. A.;
- Gong, Y.;
- Cooper-DeHoff, R. M.;
- Schork, N. J.;
- Shriver, M. D.;
- Langaee, T. Y.;
- Pepine, C. J.;
- Johnson, J. A.
Publication type:
Article
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin.
Published in:
Clinical Pharmacology & Therapeutics, 2008, v. 84, n. 3, p. 326, doi. 10.1038/clpt.2008.10
By:
- Gage, B. F.;
- Eby, C.;
- Johnson, J. A.;
- Deych, E.;
- Rieder, M. J.;
- Ridker, P. M.;
- Milligan, P. E.;
- Grice, G.;
- Lenzini, P.;
- Rettie, A. E.;
- Aquilante, C. L.;
- Grosso, L.;
- Marsh, S.;
- Langaee, T.;
- Farnett, L. E.;
- Voora, D.;
- Veenstra, D. L.;
- Glynn, R. J.;
- Barrett, A.;
- McLeod, H. L.
Publication type:
Article
Association of CYP3A5 Polymorphisms with Hypertension and Antihypertensive Response to Verapamil.
Published in:
Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 3, p. 386, doi. 10.1038/sj.clpt.6100090
By:
- Langaee, T. Y.;
- Gong, Y.;
- Yarandi, H. N.;
- Katz, D. A.;
- Cooper-DeHoff, R. M.;
- Pepine, C. J.;
- Johnson, J. A.
Publication type:
Article
OIII-B-1.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P30, doi. 10.1016/j.clpt.2005.12.110
By:
- Gong, Y.;
- Beitelshees, A. L.;
- Stauffer, L. A.;
- Langaee, T. Y.;
- Cooper-DeHoff, R. M.;
- Pepine, C. J.;
- Johnson, J. A.
Publication type:
Article
OIII-B-2.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P30, doi. 10.1016/j.clpt.2005.12.111
By:
- Shin, J.;
- Lobmeyer, M. T.;
- Gong, Y.;
- Zineh, I.;
- Langaee, T. Y.;
- Yarandi, H. N.;
- Pauly, D. F.;
- Aranda, J. M.;
- Schofield, R. S.;
- Hill, J. A.;
- Johnson, J. A.
Publication type:
Article
PII-26.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P43, doi. 10.1016/j.clpt.2005.12.151
By:
- Johnson, J. A.;
- Karnes, J. H.;
- Brunner, M.;
- Gong, Y.;
- Langaee, T. Y.;
- Cooper-DeHoff, R. M.;
- Pepine, C. J.
Publication type:
Article
PIII-7.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P59, doi. 10.1016/j.clpt.2005.12.215
By:
- Zineh, I.;
- Aquilante, C. L.;
- Langaee, T. Y.;
- Beitelshees, A. L.;
- Wessel, T. R.;
- Arant, C. B.;
- Schofield, R. S.
Publication type:
Article
OII-B-2.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P5, doi. 10.1016/j.clpt.2005.12.015
By:
- Zineh, I.;
- Langaee, T. Y.;
- Wessel, T. R.;
- Arant, C. B.;
- Schofield, R. S.
Publication type:
Article
PI-22.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P12, doi. 10.1016/j.clpt.2005.12.043
By:
- Langaee, T. Y.;
- Yarandi, H. N.;
- Katz, D. A.;
- Dehoff, R. M.;
- Kehoe, J. M.;
- Klocman, A. S.;
- Pepine, C. J.;
- Johnson, J. A.
Publication type:
Article
PI-26.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P14, doi. 10.1016/j.clpt.2005.12.047
By:
- Brunner, M.;
- Karnes, J. H.;
- Gong, Y.;
- Langaee, T. Y.;
- Cooper-DeHoff, R. M.;
- Pepine, C. J.;
- Johnson, J. A.
Publication type:
Article
PI-30<sup>*</sup>.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P15, doi. 10.1016/j.clpt.2005.12.051
By:
- Kroetz, D. L.;
- Yu, Z.;
- Langaee, T. Y.;
- Johnson, J. A.
Publication type:
Article
Association of β2-adrenergic receptor (β2AR) haplotype and hypertension in African Americans and Caucasians.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P95, doi. 10.1016/j.clpt.2003.11.362
By:
- Belgado, B. S.;
- Cavallari, L. H.;
- Langaee, T.;
- Okorochukwu, T.;
- Sloan, A.;
- Johnson, J.
Publication type:
Article
Association of CYP3A5*3, *6, and *7 polymorphisms with hypertension.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P13, doi. 10.1016/j.clpt.2003.11.050
By:
- Langaee, T. Y.;
- Givens, R. C.;
- Sloan, A.;
- Watkins, P. B.;
- Johnson, J. A.
Publication type:
Article
Association of alpha 2B-adrenergic receptor insertion/deletion polymorphism with hypertension and obesity.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P68, doi. 10.1016/S0009-9236(03)90609-6
By:
- Rantinella, R. P.;
- Langaee, T. Y.;
- Aquilante, C. L.;
- Johnson, J. A.
Publication type:
Article
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.
Published in:
Investigational New Drugs, 2014, v. 32, n. 3, p. 452, doi. 10.1007/s10637-013-0047-4
By:
- Dunbar, E.;
- Coats, B.;
- Shroads, A.;
- Langaee, T.;
- Lew, A.;
- Forder, J.;
- Shuster, J.;
- Wagner, D.;
- Stacpoole, P.
Publication type:
Article
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
Published in:
Journal of Internal Medicine, 2014, v. 276, n. 5, p. 486, doi. 10.1111/joim.12215
By:
- Vandell, A. G.;
- McDonough, C. W.;
- Gong, Y.;
- Langaee, T. Y.;
- Lucas, A. M.;
- Chapman, A. B.;
- Gums, J. G.;
- Beitelshees, A. L.;
- Bailey, K. R.;
- Johnson, R. J.;
- Boerwinkle, E.;
- Turner, S. T.;
- Cooper‐DeHoff, R. M.;
- Johnson, J. A.
Publication type:
Article
Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 2, p. 175, doi. 10.1038/clpt.2014.62
By:
- Hamadeh, I S;
- Langaee, T Y;
- Dwivedi, R;
- Garcia, S;
- Burkley, B M;
- Skaar, T C;
- Chapman, A B;
- Gums, J G;
- Turner, S T;
- Gong, Y;
- Cooper‐DeHoff, R M;
- Johnson, J A
Publication type:
Article
Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 6, p. 746, doi. 10.1038/clpt.2012.184
By:
- Danese, E;
- Montagnana, M;
- Johnson, J A;
- Rettie, A E;
- Zambon, C F;
- Lubitz, S A;
- Suarez-Kurtz, G;
- Cavallari, L H;
- Zhao, L;
- Huang, M;
- Nakamura, Y;
- Mushiroda, T;
- Kringen, M K;
- Borgiani, P;
- Ciccacci, C;
- Au, N T;
- Langaee, T;
- Siguret, V;
- Loriot, M A;
- Sagreiya, H
Publication type:
Article
Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 4, p. 437, doi. 10.1038/clpt.2012.125
By:
- Johnson, J A;
- Burkley, B M;
- Langaee, T Y;
- Clare-Salzler, M J;
- Klein, T E;
- Altman, R B
Publication type:
Article
VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.
Published in:
European Journal of Clinical Pharmacology, 2008, v. 64, n. 9, p. 889, doi. 10.1007/s00228-008-0507-5
By:
- Oner Ozgon, G.;
- Langaee, T. Y.;
- Feng, H.;
- Buyru, N.;
- Ulutin, T.;
- Hatemi, A. C.;
- Siva, A.;
- Saip, S.;
- Johnson, J. A.
Publication type:
Article
The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.
Published in:
British Journal of Clinical Pharmacology, 2005, v. 59, n. 1, p. 70, doi. 10.1111/j.1365-2125.2005.02263.x
By:
- Hruska, M. W.;
- Amico, J. A.;
- Langaee, T. Y.;
- Ferrell, R. E.;
- Fitzgerald, S. M.;
- Frye, R. F.
Publication type:
Article
Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old.
Published in:
Iranian Journal of Pediatric Hematology & Oncology, 2016, v. 6, n. 1, p. 24
By:
- H., Farhangi;
- A., Ghasemi;
- A., Banihashem;
- Z., Badiei;
- L., Jarahi;
- G., Eslami;
- T., Langaee
Publication type:
Article
Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in children.
Published in:
Journal of Clinical Pharmacology, 2015, v. 55, n. 1, p. 50, doi. 10.1002/jcph.371
By:
- Shroads, A. L.;
- Coats, B. S.;
- McDonough, C. W.;
- Langaee, T.;
- Stacpoole, P. W.
Publication type:
Article
Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population.
Published in:
CTS: Clinical & Translational Science, 2016, v. 9, n. 1, p. 23, doi. 10.1111/cts.12383
By:
- Khalil, BM;
- Shahin, MH;
- Solayman, MHM;
- Langaee, T;
- Schaalan, MF;
- Gong, Y;
- Hammad, LN;
- Al‐Mesallamy, HO;
- Hamdy, NM;
- El‐Hammady, WA;
- Johnson, JA
Publication type:
Article

Found: 29

Epigenetic regulation of inflammation in localized aggressive periodontitis.

Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.

Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.

Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans.

Promoter Polymorphisms in ACE (Angiotensin I–Converting Enzyme) Associated With Clinical Outcomes in Hypertension.

β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension.

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin.

Association of CYP3A5 Polymorphisms with Hypertension and Antihypertensive Response to Verapamil.

OIII-B-1.

OIII-B-2.

PII-26.

PIII-7.

OII-B-2.

PI-22.

PI-26.

PI-30<sup>*</sup>.

Association of β2-adrenergic receptor (β2AR) haplotype and hypertension in African Americans and Caucasians.

Association of CYP3A53, 6, and *7 polymorphisms with hypertension.

Association of alpha 2B-adrenergic receptor insertion/deletion polymorphism with hypertension and obesity.

Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.

Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.

Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate.

Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis.

Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array.

VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.

The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.

Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old.

Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in children.

Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population.